Volume 2, Issue 1, February 2014, Page: 28-33
Studies on Lipid Profile Levels in Hypertensive and Type 2 Diabetes Mellitus
Ajuru, Gospel, Department of Anatomical Pathology, Faculty of Basic Medical Science, University of Port Harcourt, Choba, Nigeria
Okolonkwo, Benjamin, Department of Medical Laboratory Science, Faculty of Science, Rivers State University of Science and Technology, Port Harcourt, Nigeria
Okeke, Chukwubike, Department of Prosthesis and Orthopedic Technology, Federal University of Technology, Owerri, Nigeria
Received: Feb. 10, 2014;       Published: Mar. 20, 2014
DOI: 10.11648/j.ajbls.20140201.15      View  2315      Downloads  130
Abstract
Studies on the effect of non-hypertensive and hypertensive type 2 diabetes on lipid profile was performed to determine whether these biochemical parameters were affected in individuals associated with these disease conditions. A total of one hundred and thirty-three (133) individuals were used for these studies. Of these thirty-five (35) were established hypertensive diabetics and thirty (30) are established non-hypertensive diabetics. The established hypertensive non-diabetics were thirty-three (33) while thirty-five (35) were normal healthy individuals. The results showed that there was no significant differences (P>0.05) in the mean concentrations of cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol and glucose between hypertensive diabetics and non-hypertensive diabetics studied. The study also showed that there were no significance differences (P>0.05) in the mean levels of all the parameters measured between hypertensive diabetics and hypertensive non-diabetics subjects studied, except for serum glucose that significantly higher (P<0.05) in hypertensive diabetics. It was observed that mean concentrations of cholesterol, triglycerides, LDC-cholesterol, as well as systolic blood pressure were significantly higher (P<0.05) in hypertensive diabetics compared with normal healthy individuals. The results also show that the mean HDL-cholesterol level was significantly lower (P>0.05) in hypertensive diabetics compared with normal healthy individuals. It was also observed that the concentrations of cholesterol, triglycerides, LDL-cholesterol systolic and diastolic blood pressure were significantly higher (P>0.05) in hypertensive non diabetics individuals compared with normal healthy individuals studied. However, the glucose and pulse rate mean levels showed no significant difference (P>0.05) between hypertensive non-diabetics and normal healthy individuals.
Keywords
Hypertension, Type 2 Diabetics
To cite this article
Ajuru, Gospel, Okolonkwo, Benjamin, Okeke, Chukwubike, Studies on Lipid Profile Levels in Hypertensive and Type 2 Diabetes Mellitus, American Journal of Biomedical and Life Sciences. Vol. 2, No. 1, 2014, pp. 28-33. doi: 10.11648/j.ajbls.20140201.15
Reference
[1]
Mayne, DP. Plasma Lipids and Lipometenis, in: Clinical Chemistry in Diagnosis and Treatment. Sixth edition, Oxford University Press, Inco. New York; 1996.
[2]
Grundy SM, Pasternak R Greenland P. (1999). Assessment of Cardiovascular Risk Factor, Assessment Equation Journal of American glucose of Cardiology. 1999; 34:1248-1359.
[3]
Wilson PH, Dagostino RB, Levy D. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulations. 1998; 97;1837-1847.
[4]
Harlan WR. Cardiovascular Disease Care for Women: Service Utilization, Disability Utilization, and Expenditure Survey. In: Eaker ED, Packard B, Wenaer NK, Clarkson TB, Tyroler HA’s Coronary Heart Disease in Women. 4th Ed, New York, Haymanket Doyma; 1986
[5]
Harris MI, Hadden WC, Knowler WC, Bennet PH. Mevalence of Diabetus and Impaired Glucose Tolerance and Plasma Glucose levels in U.S. Population aged 20-74 years Diabetics. 1987; 36:523-523, 534.
[6]
Sokolow M, Malwen BM. Coronary Disease In: Clinical Cardiology, 2nd edition, Lans Medical Publications, California; 1979
[7]
Tietz NW. Lipid, Apolipopotients. In: Fundamentals of Clinical Chemistry, 6th edition, WB Saunders Company, London; 2003
[8]
Alderman MH, Cohen H, Mad Haven S, Kivilann S. Serum Uric acid and Cardiovascular Disease events in Successfully Treated Hypertensive Patient. Hypertensive. 1999; 34:144-150.
[9]
Bishop ML, Duben, Engelkiri, JL, Fody, EP. Carbohydrate, Diabetes mellitus. In: Clinical chemistry, Principles, Procedures, Correlations, 2nd edition, J.B. Lippincott company, 1991.
[10]
Roberts WC. Preventing and Arresting Coronary Atherosileresis. American heat Journal. 1995; 130:580-597.
[11]
Lehninger AL. The biosynthesis of lipids. In: Principles of Biochemistry, 2nd edition, Worth Publishers Inc, New York. 1993
[12]
Garcia A, Gutiierrez JM, Fernandez S, Aparicio J, Menendez PA. Dietary Intervention in a Hypercholustero-lemic School Aged Population from Northern Spain. Journal of Revolution of Physiology. 1996; 52:49-58.
[13]
Trinder P. Diagnosis of Coronary Heart Disease. Annals of Clinical Biochemistry. 1997; 6: 24.
[14]
Tilkian MS, Conover BM, Tilkian GA. Clinical Implications of Laboratory Tests; 2nd edition, the C.V. mosby company, London. 1979
[15]
Kaplan A, Szabo LL, Opheim, EK. Clinical interpretation and techniques, 3rd edition, Lee and Febiger, Philadelphia. 1988.
Browse journals by subject